丹麦王国的TMS:当前临床实践的概述
Pedro Cabral Barata1,2,3, Sónia Pimenta Alves4, Alexander T Sack3
1Regionspsykiatrien Gødstrup, Herning, Denmark.
Nordic journal of psychiatry
|November 30, 2024
概括
在37%的丹麦精神病科中,可使用重复性横磁性刺激 (rTMS),主要用于治疗耐药单极性抑郁症. 实践与国际指导方针一致,但显示丹麦内部的机会不平等.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗技术 医疗技术 医学技术
背景情况:
- 重复性横磁性刺激 (rTMS) 是神经精神疾病的一种成熟治疗方法.
- 经批准的rTMS设备确保了安全性和有效性.
- 对于RTMS实践,已有国际指导方针.
研究的目的:
- 调查丹麦目前的RTMS临床实践.
- 将丹麦的rTMS实践与国际标准进行比较.
主要方法:
- 一项2023年调查分发给所有丹麦精神病学部门,使用rTMS.
- 实现了100%的响应率.
主要成果:
- 在丹麦3个地区的37%的部门,rTMS可用.
- 单极性抑郁症是rTMS治疗的唯一适应症.
- 常见的禁忌包括植入物和滥用物质.
- 他们确定了三个协议:10 Hz rTMS,iTBS和1 Hz rTMS.
- 383名患者接受了TMS治疗.
结论:
- 在丹麦的公共医疗保健中,RTMS的可用性是不平等的.
- 需要制定战略来解决接入不平等的问题.
- 丹麦的rTMS协议是基于证据的,并与国际建议保持一致.
更多相关视频
08:24Conventional and Threshold-Tracking Transcranial Magnetic Stimulation Tests for Single-handed Operation
Published on: August 16, 2021
5.8K
09:33Neuronavigated Focalized Transcranial Direct Current Stimulation Administered During Functional Magnetic Resonance Imaging
Published on: November 15, 2024
1.2K
相关概念视频
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
